BRCA1/2 potential founder variants in the Jordanian population: an opportunity for a customized screening panel

A founder variant is a genetic alteration, that is inherited from a common ancestor together with a surrounding chromosomal segment, and is observed at a high frequency in a defined population. This founder effect occurs as a consequence of long-standing inbreeding of isolated populations. For high-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ahmad, Olfat (VerfasserIn) , Sutter, Christian (VerfasserIn) , Hirsch, Steffen (VerfasserIn) , Pfister, Stefan (VerfasserIn) , Schaaf, Christian P. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2023
In: Hereditary cancer in clinical practice
Year: 2023, Jahrgang: 21, Pages: 1-9
ISSN:1897-4287
DOI:10.1186/s13053-023-00256-2
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13053-023-00256-2
Verlag, kostenfrei, Volltext: https://hccpjournal.biomedcentral.com/articles/10.1186/s13053-023-00256-2
Volltext
Verfasserangaben:Olfat Ahmad, Christian Sutter, Steffen Hirsch, Stefan M. Pfister and Christian P. Schaaf
Beschreibung
Zusammenfassung:A founder variant is a genetic alteration, that is inherited from a common ancestor together with a surrounding chromosomal segment, and is observed at a high frequency in a defined population. This founder effect occurs as a consequence of long-standing inbreeding of isolated populations. For high-risk cancer predisposition genes, such as BRCA1/2, the identification of founder variants in a certain population could help designing customized cost-effective cancer screening panels. This advantage has been best utilized in designing a customized breast cancer BRCA screening panel for the Ashkenazi Jews (AJ) population, composed of the three BRCA founder variants which account for approximately 90% of identified BRCA alterations. Indeed, the high prevalence of pathogenic BRCA1/2 variants among AJ (~ 2%) has additionally contributed to make population-based screening cost-effective in comparison to family-history-based screening. In Jordan there are multiple demographic characteristics supporting the proposal of a founder effect. A high consanguinity rate of ~ 57% in the nineties of the last century and ~ 30% more recently is a prominent factor, in addition to inbreeding which is often practiced by different sub-populations of the country.
Beschreibung:Veröffentlicht: 3. Juli 2023
Gesehen am 22.08.2023
Beschreibung:Online Resource
ISSN:1897-4287
DOI:10.1186/s13053-023-00256-2